Filters: Author is Friedland, Gerald [Clear All Filters]
"Lack of an effect of atazanavir on steady-state pharmacokinetics of methadone in patients chronically treated for opiate addiction." AIDS (London, England) 19, no. 15 (2005): 1635-41. Abstract
"Report from the Tenth Retrovirus Conference. Clinical trials in resource-poor settings." AIDS clinical care 15, no. 4 (2003): 31-2.
"Administration of efavirenz (600 mg/day) with rifampicin results in highly variable levels but excellent clinical outcomes in patients treated for tuberculosis and HIV." The Journal of antimicrobial chemotherapy 58, no. 6 (2006): 1299-302. Abstract
"Infectious disease comorbidities adversely affecting substance users with HIV: hepatitis C and tuberculosis." Journal of acquired immune deficiency syndromes (1999) 55 Suppl 1 (2010): S37-42. Abstract
"Utility of tuberculosis directly observed therapy programs as sites for access to and provision of antiretroviral therapy in resource-limited countries." Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 38 Suppl 5 (2004): S421-8. Abstract
"Discovery of the function of the heart and circulation of blood." Cardiovascular journal of Africa 20, no. 3 (2009): 160.
"Integration of buprenorphine for substance-abuse treatment by HIV care providers." Journal of acquired immune deficiency syndromes (1999) 56 Suppl 1 (2011): S1-2.
"Marking Time in the Global HIV/AIDS Pandemic." JAMA 316, no. 2 (2016): 145-6.
"Protecting health care workers: the critical role of airborne infection control." The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease 12, no. 6 (2008): 585.
"Implementation issues in tuberculosis/HIV program collaboration and integration: 3 case studies." The Journal of infectious diseases 196 Suppl 1 (2007): S114-23. Abstract
"Computer-based intervention in HIV clinical care setting improves antiretroviral adherence: the LifeWindows Project." AIDS and behavior 15, no. 8 (2011): 1635-46. Abstract
"HIV Prevention Counseling Intervention Delivered During Routine Clinical Care Reduces HIV Risk Behavior in HIV-Infected South Africans Receiving Antiretroviral Therapy: The Izindlela Zokuphila/Options for Health Randomized Trial." Journal of acquired immune deficiency syndromes (1999) (2014). Abstract
"Trends in hospital deaths among human immunodeficiency virus-infected patients during the antiretroviral therapy era, 1995 to 2011." Journal of hospital medicine (2015). Abstract
"Opportunities afforded by new drugs for tuberculosis." The Lancet infectious diseases 10, no. 6 (2010): 368-9.
"Therapeutic response of HIV-1 subtype C in African patients coinfected with either Mycobacterium tuberculosis or human herpesvirus-8." The Journal of infectious diseases 191, no. 3 (2005): 324-32. Abstract
"The impact of episodic CD4 cell count-guided antiretroviral therapy on quality of life." Journal of acquired immune deficiency syndromes (1999) 47, no. 2 (2008): 185-93. Abstract
"Episodic antiretroviral therapy increases HIV transmission risk compared with continuous therapy: results of a randomized controlled trial." Journal of acquired immune deficiency syndromes (1999) 49, no. 2 (2008): 142-50. Abstract
"Multidrug-resistant and extensively drug-resistant tuberculosis: implications for the HIV epidemic and antiretroviral therapy rollout in South Africa." The Journal of infectious diseases 196 Suppl 3 (2007): S482-90. Abstract
"Predictors of multidrug- and extensively drug-resistant tuberculosis in a high HIV prevalence community." PloS one 5, no. 12 (2010): e15735. Abstract
"Exogenous reinfection as a cause of multidrug-resistant and extensively drug-resistant tuberculosis in rural South Africa." The Journal of infectious diseases 198, no. 11 (2008): 1582-9. Abstract
"Implementing antiretroviral therapy in resource-constrained settings: opportunities and challenges in integrating HIV and tuberculosis care." AIDS (London, England) 18, no. 7 (2004): 975-9.
"The SAPIT trial provides essential evidence on risks and benefits of integrated and sequential treatment of HIV and tuberculosis." South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde 100, no. 12 (2010): 808-9.
"Integration of antiretroviral therapy with tuberculosis treatment." The New England journal of medicine 365, no. 16 (2011): 1492-501. Abstract
"Timing of initiation of antiretroviral drugs during tuberculosis therapy." The New England journal of medicine 362, no. 8 (2010): 697-706. Abstract
